In mice bearing tumors, including colon tumors, breast tumors and chemically induced fibrosarcomas, treatment with an mAb to TIGIT induced tumor growth inhibition and tumor volume reduction and prevented NK-cell exhaustion. Here, TIGIT is linked to neoplasm.